NOD.B6-(D17Mit114-D17Mit101)/Orl

Status

Available to order

EMMA IDEM:01402
International strain nameNOD.B6-(D17Mit114-D17Mit101)/Orl
Alternative nameNOD.B6-C17(R76.22)
Strain typeSpontaneous
Allele/Transgene symbolIdd16.1, Ceat1
Gene/Transgene symbolIdd16.1, Ceat1

Information from provider

ProviderHenri-Jean Garchon
Provider affiliationER70 CNRS et Unite 125 Inserm
Genetic informationNOD subcongenic strain with an interval proximal to the H2 complex from C57BL/6. The R76.22 interval is derived from R76.
Phenotypic informationThis line and the related lines, consomic, congenic and subcongenic for chromosome 17 and fragments of this chromosome, were derived to thoroughly investigate the role of the major histocompatibility complex (MHC) and MHC-linked genes in autoimmune predisposition, notably including type I diabetes (Idd1 and Idd16) loci and chronic autoimmune thyroiditis (Ceat1) locus, on the non-obese diabetic (NOD) background. The R76.22 line is partially protected against type 1 diabetes and defines the Idd16.1 locus for type 1 diabetes. Some of the frozen embryos have been obtained thanks to a crossing between an homozygous male and a NOD wild-type females.
Breeding history20 generations of backcrosses followed by sister-brother matings. Selection of subcongenics by additional backcrosses.
ReferencesNone available

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France

Disease and phenotype information

MGI phenotypes (gene matching)
  • abnormal thyroid physiology / MGI
  • increased susceptibility to experimental autoimmune thyroiditis / MGI
  • pancreas inflammation / MGI
  • abnormal glucose homeostasis / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).